We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Hologic and Agfa Finalize Development/Purchase Agreement

By HospiMedica staff writers
Posted on 24 Mar 2003
Following a joint development and OEM (original equipment manufacturer) purchase agreement in April 2002, Hologic, Inc. (Beford, MA, USA) and Agfa-Gevaert Group (Mortsel, Belgium) have now announced the final terms of that agreement.

Under these terms, Hologic will manufacture for Agfa, under the private label "Embrace,” a digital mammography system for distribution to specific international markets. The system will utilize Hologic's patented direct-to-digital amorphous selenium technology, which will be combined with Agfa's portfolio of image and information management systems. A leading imaging company, Agfa is active in 40 countries and has 120 agents throughout the world.

"Finalizing this agreement with Agfa-Gevaert moves us one step closer to making our direct capture digital mammography technology widely available on a global basis to healthcare providers and the women they serve,” said Jack Cummings, chairman and CEO of Hologic. The company's core business units are focused on osteoporosis assessment, mammography and breast biopsy, direct-to-digital x-ray for general radiography, and mini C-arm for orthopedic applications.




Related Links:
Hologic
Agfa
Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Syringe Pump
SP50 Series

Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more